-
1
-
-
34250158434
-
Salt, blood pressure and cardiovascular disease
-
DOI: 10.1097/HCO.0b013e32814f1d8c
-
F. He and G. MacGregor, Salt, blood pressure and cardiovascular disease, Curr. Opin. Cardiol. 22 (2007) 298-305; DOI: 10.1097/HCO.0b013e32814f1d8c.
-
(2007)
Curr. Opin. Cardiol.
, vol.22
, pp. 298-305
-
-
He, F.1
MacGregor, G.2
-
2
-
-
0036224563
-
Angiotensin II receptor antagonists role in arterial hypertension
-
DOI: 10.1038/sj/jhh/1001352
-
R. Hernandez-Hernandez, B. Sosa-Canache, M. Velasco, M. J. Armas-Hernandez, M. C. Armas- -Padilla and R. Cammarata, Angiotensin II receptor antagonists role in arterial hypertension, J. Hum. Hypertens. 16 (2002) S93-99; DOI: 10.1038/sj/jhh/1001352.
-
(2002)
J. Hum. Hypertens.
, vol.16
-
-
Hernandez-Hernandez, R.1
Sosa-Canache, B.2
Velasco, M.3
Armas-Hernandez, M.J.4
Armas- -Padilla, M.C.5
Cammarata, R.6
-
3
-
-
0029588499
-
Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans
-
DOI: 10.1016/0009-9236(95)90020-9
-
M. W. Lo, M. R. Goldberg, J. B. McCrea, H. Lu, C. I. Furtek and T. D. Bjornsson, Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans, Clin. Pharmacol. Ther. 58 (1995) 641-649; DOI: 10.1016/0009-9236(95)90020-9.
-
(1995)
Clin. Pharmacol. Ther.
, vol.58
, pp. 641-649
-
-
Lo, M.W.1
Goldberg, M.R.2
McCrea, J.B.3
Lu, H.4
Furtek, C.I.5
Bjornsson, T.D.6
-
4
-
-
34248575520
-
Intranasal delivery: Physicochemical and therapeutic aspects
-
DOI: 10.1016/j.ijpharm.2007.03.025
-
H. R. Costantino, L. Illum, G. Brandt, P. H. Johnson and S. C. Quay, Intranasal delivery: physicochemical and therapeutic aspects, Int. J. Pharm. 337 (2007) 1-24; DOI: 10.1016/j.ijpharm.2007.03.025.
-
(2007)
Int. J. Pharm.
, vol.337
, pp. 1-24
-
-
Costantino, H.R.1
Illum, L.2
Brandt, G.3
Johnson, P.H.4
Quay, S.C.5
-
5
-
-
26644434124
-
Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
-
DOI: 10.1016/j.addr.2005.07.009
-
M. I. Ugwoke, R. U. Agu, N. Verbeke and R. Kinget, Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives, Adv. Drug Deliv. Rev. 57 (2005) 1640-1665, DOI: 10.1016/j.addr.2005.07.009.
-
(2005)
Adv. Drug Deliv. Rev.
, vol.57
, pp. 1640-1665
-
-
Ugwoke, M.I.1
Agu, R.U.2
Verbeke, N.3
Kinget, R.4
-
6
-
-
74849091468
-
Situ and ex vivo nasal models for preclinical drug development studies
-
(Eds. C. Ehrhardt and K. Kim), AAPS Pharmaceutical Press, New York DOI: 10.1007/978-0-387-74901-3-5
-
R. Agu and M. Ugwoke, In Situ and Ex Vivo Nasal Models for Preclinical Drug Development Studies, in Drug Absorption Studies in Situ, in Vivo and In Silico Models (Eds. C. Ehrhardt and K. Kim), AAPS Pharmaceutical Press, New York 2008, pp. 112-134; DOI: 10.1007/978-0-387-74901-3-5.
-
(2008)
Drug Absorption Studies in Situ, in Vivo and in Silico Models
, pp. 112-134
-
-
Agu, R.1
Ugwoke, M.2
-
7
-
-
3242673511
-
Cyclodextrins in nasal delivery of low-molecular-weight heparins: In vivo and in vitro studies
-
DOI: 10.1023/B:PHAM.0000032998.84488.7a
-
T. Yang, A. Hussain, J. Paulson, T. J. Abbruscato and F. Ahsan, Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies, Pharm. Res. 21 (2004) 1127-1136; DOI: 10.1023/B:PHAM.0000032998. 84488.7a.
-
(2004)
Pharm. Res.
, vol.21
, pp. 1127-1136
-
-
Yang, T.1
Hussain, A.2
Paulson, J.3
Abbruscato, T.J.4
Ahsan, F.5
-
8
-
-
34248674912
-
Effects of a sperminated gelatin on the nasal absorption of insulin
-
DOI: 10.1016/j.ijpharm. 2007.02.004
-
T. Seki, H. Kanbayashi, S. Chono, Y. Tabata and K. Morimoto, Effects of a sperminated gelatin on the nasal absorption of insulin, Int. J. Pharm. 338 (2007) 213-218; DOI: 10.1016/j.ijpharm. 2007.02.004.
-
(2007)
Int. J. Pharm.
, vol.338
, pp. 213-218
-
-
Seki, T.1
Kanbayashi, H.2
Chono, S.3
Tabata, Y.4
Morimoto, K.5
-
9
-
-
7544236962
-
Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)] teriparatide in rats
-
DOI: 10.1081/ERC-200035957
-
R. U. Agu, S. Valiveti, D. C. Earles, M. Klausner, P. J. Hayden, D. P. Wermeling and A. L. Stinchcomb, Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in rats, Endocr. Res. 30 (2004) 455-467; DOI: 10.1081/ERC-200035957.
-
(2004)
Endocr. Res.
, vol.30
, pp. 455-467
-
-
Agu, R.U.1
Valiveti, S.2
Earles, D.C.3
Klausner, M.4
Hayden, P.J.5
Wermeling, D.P.6
Stinchcomb, A.L.7
-
10
-
-
27644438661
-
Comparison of human tracheal/ bronchial epithelial cell culture and bovine nasal respiratory explants for nasal drug transport studies
-
DOI: 10.1002/jps.20404
-
N. V. Chemuturi, P. Hayden, M. Klausner and M. D. Donovan, Comparison of human tracheal/ bronchial epithelial cell culture and bovine nasal respiratory explants for nasal drug transport studies, J. Pharm. Sci. 94 (2005) 1976-1985; DOI: 10.1002/jps.20404.
-
(2005)
J. Pharm. Sci.
, vol.94
, pp. 1976-1985
-
-
Chemuturi, N.V.1
Hayden, P.2
Klausner, M.3
Donovan, M.D.4
-
11
-
-
2542448091
-
Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium
-
DOI: 10.1016/j.peptides.2004.02.019
-
R. U. Agu, H. Vu Dang, M. Jorissen, R. Kinget and N. Verbeke, Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium, Peptides 25 (2004) 563-569; DOI: 10.1016/j.peptides.2004.02.019.
-
(2004)
Peptides
, vol.25
, pp. 563-569
-
-
Agu, R.U.1
Vu Dang, H.2
Jorissen, M.3
Kinget, R.4
Verbeke, N.5
-
12
-
-
34249895912
-
Novel L-dopa and dopamine prodrugs containing a 2-phenyl- -imidazopyridine moiety
-
DOI: 10.1007/s11095-007-9255-y
-
N. Denora, V. Laquintana, A. Lopedota, M. Serra, L. Dazzi, G. Biggio, D. Pal, A. K. Mitra, A. Latrofa, G. Trapani and G. Liso, Novel L-dopa and dopamine prodrugs containing a 2-phenyl- -imidazopyridine moiety, Pharm. Res. 24 (2007) 1309-1324; DOI: 10.1007/s11095-007-9255-y.
-
(2007)
Pharm. Res.
, vol.24
, pp. 1309-1324
-
-
Denora, N.1
Laquintana, V.2
Lopedota, A.3
Serra, M.4
Dazzi, L.5
Biggio, G.6
Pal, D.7
Mitra, A.K.8
Latrofa, A.9
Trapani, G.10
Liso, G.11
-
13
-
-
0034690944
-
Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection
-
DOI: 10.1016/S0378-5173(00)00453-1
-
P. K. Yeung, A. Jamieson, G. J. Smith, D. Fice and P. T. Pollak, Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection, Int. J. Pharm. 204 (2000) 17-22; DOI: 10.1016/S0378-5173(00)00453-1.
-
(2000)
Int. J. Pharm.
, vol.204
, pp. 17-22
-
-
Yeung, P.K.1
Jamieson, A.2
Smith, G.J.3
Fice, D.4
Pollak, P.T.5
-
14
-
-
0034061961
-
Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and Caco-2 cell monolayers
-
DOI: 10.1038/sj.bjp.0703150
-
A. Soldner, L. Z. Benet, E. Mutschler and U. Christians, Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and Caco-2 cell monolayers, Br. J. Pharmacol. 129 (2000) 1235-1243; DOI: 10.1038/sj.bjp.0703150.
-
(2000)
Br. J. Pharmacol.
, vol.129
, pp. 1235-1243
-
-
Soldner, A.1
Benet, L.Z.2
Mutschler, E.3
Christians, U.4
-
15
-
-
0029865476
-
Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption
-
DOI: 10.1023/A:1016086930019
-
M. D. Ribadeneira, B. J. Aungst, C. J. Eyermann and S. M. Huang, Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption, Pharm. Res. 13 (1996) 227-233; DOI: 10.1023/A:1016086930019.
-
(1996)
Pharm. Res.
, vol.13
, pp. 227-233
-
-
Ribadeneira, M.D.1
Aungst, B.J.2
Eyermann, C.J.3
Huang, S.M.4
-
16
-
-
1542376174
-
Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: A comparative analysis in paired tissue specimens
-
DOI: 10.1016/j.clpt.2003.10.008
-
O. von Richter, O. Burk, M. F. Fromm, K. P. Thon, M. Eichelbaum and K. T. Kivistö, Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens, Clin. Pharmacol. Ther. 75 (2004) 172-83; DOI: 10.1016/j.clpt.2003.10. 008.
-
(2004)
Clin. Pharmacol. Ther.
, vol.75
, pp. 172-183
-
-
Von Richter, O.1
Burk, O.2
Fromm, M.F.3
Thon, K.P.4
Eichelbaum, M.5
Kivisto, K.T.6
-
17
-
-
0035206717
-
Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3)
-
DOI: 10.1038/sj.bjp.0704390
-
B. I. Florea, I. C. van der Sandt, S. M. Schrier, K. Kooiman, K. Deryckere, A. G. de Boer, H. E. Junginger and G. Borchard, Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3), Br. J. Pharmacol. 134 (2001) 1555-1563; DOI: 10.1038/sj.bjp.0704390.
-
(2001)
Br.J. Pharmacol.
, vol.134
, pp. 1555-1563
-
-
Florea, B.I.1
Van Der Sandt, I.C.2
Schrier, S.M.3
Kooiman, K.4
Deryckere, K.5
De Boer, A.G.6
Junginger, H.E.7
Borchard, G.8
-
18
-
-
24644443825
-
Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines
-
DOI: 10.1016/j.ejps.2005.06.004
-
T. Korjamo, P. Honkakoski, M. R. Toppinen, S. Niva, M. Reinisalo, J. J. Palmgrén and J. Mönkkönen, Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines, Eur. J. Pharm. Sci. 26 (2005) 266-279; DOI: 10.1016/j.ejps.2005.06.004.
-
(2005)
Eur. J. Pharm. Sci.
, vol.26
, pp. 266-279
-
-
Korjamo, T.1
Honkakoski, P.2
Toppinen, M.R.3
Niva, S.4
Reinisalo, M.5
Palmgrén, J.J.6
Mönkkönen, J.7
-
19
-
-
0026731720
-
Cyclodextrins as nasal absorption promoters of insulin: Mechanistic evaluations
-
DOI: 10.1023/A:1015847604654
-
Z. Shao, R. Krishnamoorthy and A. K. Mitra, Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations, Pharm. Res. 9 (1992) 1157-1163; DOI: 10.1023/A:1015847604654.
-
(1992)
Pharm. Res.
, vol.9
, pp. 1157-1163
-
-
Shao, Z.1
Krishnamoorthy, R.2
Mitra, A.K.3
-
20
-
-
0034945941
-
Nasal bioavailability of peptide T in rabbits: Absorption enhancement by sodium glycocholate and glycofurol
-
DOI: 10.1016/S0928-0987(01)00146-4
-
M. A. Bagger, H. W. Nielsen and E. Bechgaard, Nasal bioavailability of peptide T in rabbits: absorption enhancement by sodium glycocholate and glycofurol, Eur. J. Pharm Sci. 14 (2001) 69-74; DOI: 10.1016/S0928-0987(01) 00146-4.
-
(2001)
Eur. J. Pharm Sci.
, vol.14
, pp. 69-74
-
-
Bagger, M.A.1
Nielsen, H.W.2
Bechgaard, E.3
|